Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach
Kazi Faizul Azim, Sheikh Rashel Ahmed, Anik Banik, et al.
Informatics in Medicine Unlocked (2020) Vol. 20, pp. 100367-100367
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
Yan-Rong Guo, Qing-Dong Cao, Zhong-Si Hong, et al.
Military Medical Research (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 4721
The COVID‐19 epidemic
Thirumalaisamy P. Velavan, Christian G. Meyer
Tropical Medicine & International Health (2020) Vol. 25, Iss. 3, pp. 278-280
Open Access | Times Cited: 2365
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
Eakachai Prompetchara, Chutitorn Ketloy, Tanapat Palaga
Asian Pacific Journal of Allergy and Immunology (2020)
Open Access | Times Cited: 1563
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong, Shasha Hu, Jianjun Gao
Drug Discoveries & Therapeutics (2020) Vol. 14, Iss. 1, pp. 58-60
Open Access | Times Cited: 1417
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Hongzhou Lu
BioScience Trends (2020) Vol. 14, Iss. 1, pp. 69-71
Open Access | Times Cited: 1178
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Philippe Colson, Jean‐Marc Rolain, Jean‐Christophe Lagier, et al.
International Journal of Antimicrobial Agents (2020) Vol. 55, Iss. 4, pp. 105932-105932
Open Access | Times Cited: 966
What we know so far: COVID-19 current clinical knowledge and research
M. Alexandra Lake
Clinical Medicine (2020) Vol. 20, Iss. 2, pp. 124-127
Open Access | Times Cited: 804
COVID-19 (Novel Coronavirus 2019) - recent trends.
Kannan Subbaram, P. Shaik Syed Ali, A. Sheeza, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2020) Vol. 24, Iss. 4, pp. 2006-2011
Closed Access | Times Cited: 510
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option
Tiantian Yao, Jiandan Qian, Wen‐Yan Zhu, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 6, pp. 556-563
Open Access | Times Cited: 481
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Farhana Rumzum Bhuiyan, Sabbir Howlader, Topu Raihan, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 161
Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors
Negar Balmeh, Samira Mahmoudi, Niloofar Mohammadi, et al.
Informatics in Medicine Unlocked (2020) Vol. 20, pp. 100407-100407
Open Access | Times Cited: 77
An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations
Shiv Kumar Prajapati, Akanksha Malaiya, Gaurav Mishra, et al.
Journal of Ethnopharmacology (2022) Vol. 296, pp. 115420-115420
Open Access | Times Cited: 27
Synthesis, biological and computational studies of flavonoid acetamide derivatives
Daniel Isika, Fatma Nur Özkömeç, Mustafa Çeşme, et al.
RSC Advances (2022) Vol. 12, Iss. 16, pp. 10037-10050
Open Access | Times Cited: 23
Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine
Mst Rubaiat Nazneen Akhand, Kazi Faizul Azim, Syeda Farjana Hoque, et al.
Infection Genetics and Evolution (2020) Vol. 85, pp. 104517-104517
Open Access | Times Cited: 32
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations
Son Tung Ngo, Hung Minh Nguyen, Le Thi Thuy Huong, et al.
RSC Advances (2020) Vol. 10, Iss. 66, pp. 40284-40290
Open Access | Times Cited: 29
Identification of potential antivirals against SARS-CoV-2 using virtual screening method
Mohammad Rejaur Rahman, Anik Banik, Ishtiak Malique Chowdhury, et al.
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100531-100531
Open Access | Times Cited: 23
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 17
Molecular docking and machine learning affinity prediction of compounds identified upon softwood bark extraction to the main protease of the SARS-CoV-2 virus
Michal Jablonský, Marek Štekláč, Veronika Majová, et al.
Biophysical Chemistry (2022) Vol. 288, pp. 106854-106854
Open Access | Times Cited: 12
Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach
Mahmudul Hasan, Kazi Faizul Azim, Md. Abdus Shukur Imran, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237181-e0237181
Open Access | Times Cited: 18
Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family
Kazi Faizul Azim, Tahera Lasker, Rahima Akter, et al.
Heliyon (2021) Vol. 7, Iss. 5, pp. e07022-e07022
Open Access | Times Cited: 13
Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2
Pattnaik Subhaswaraj, Siddhardha Busi
Elsevier eBooks (2022), pp. 207-246
Closed Access | Times Cited: 8
Looking for SARS-CoV-2 Therapeutics Through Computational Approaches
Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone
Current Medicinal Chemistry (2022) Vol. 30, Iss. 28, pp. 3158-3214
Closed Access | Times Cited: 8
Inhibitory potential of plant-derived metabolites against Zika virus: a computational-aided approach
Sheikh Rashel Ahmed, Anik Banik, Sadia Mahjabin Anni, et al.
Phytomedicine Plus (2021) Vol. 1, Iss. 4, pp. 100129-100129
Open Access | Times Cited: 10
Exploring the Fatty Acid Binding Pocket in the SARS-CoV-2 Spike Protein – Confirmed and Potential Ligands
Luís Queirós-Reis, João R. Mesquita, Andrea Brancale, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 23, pp. 7282-7298
Open Access | Times Cited: 3
Seawater fungi-derived compound screening to identify novel small molecules against dengue virus NS5 methyltransferase and NS2B/NS3 protease
Mahamudul Hasan, Md. Mukthar Mia, Shahab Uddin Munna, et al.
Informatics in Medicine Unlocked (2022) Vol. 30, pp. 100932-100932
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top